Clinical trial
Torque Teno Virus: A Biomarker of Immunosuppression in Kidney Transplantation, an Observational Single Centre Study
NCT05756036 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Torque Teno Virus: A Biomarker of Immunosuppression in Kidney Transplantation, an Observational Single Centre Study
- Lead sponsor
- Queen Mary University of London
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 15, 2022
- Completion date
- August 31, 2025
- Enrollment
- 268 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
immunosuppression, renal transplant failure, renal transplant infection, renal transplant rejection